CMS releases proposed updates to quality payment program

On July 14, the Centers for Medicare & Medicaid Services released the 2027 Medicare Physician Fee Schedule (PFS) proposed rule, which includes potential revisions to the quality payment program. Highlights of the proposed revisions that may affect sleep medicine professionals include:  CMS is proposing to phase out the traditional Merit-based Incentive Payment System (MIPS) reporting option after the CY 2028 performance period. Beginning [...]

2026-07-31T14:45:05-05:00July 31st, 2026|Clinical Resources, Payer Advocacy|

AASM submits comments on CMS interoperability and prior authorization proposed rule

On April 14, 2026, the Centers for Medicare & Medicaid Services (CMS) published the Interoperability Standards and Prior Authorization for Drugs Proposed Rule, representing a significant step toward modernizing prior authorization processes and expanding interoperability across the healthcare system. These efforts directly affect sleep [...]

2026-07-27T15:51:47-05:00June 16th, 2026|Advocacy, Payer Advocacy|

States challenge private insurer E/M downcoding

States and professional organizations are increasingly challenging private insurers' downcoding of evaluation and management (E/M) services, a practice clinicians say undermines physician judgment and delays appropriate reimbursement. E/M downcoding occurs when payers automatically reduce the level of a clinician-reported E/M code, resulting in [...]

2026-04-10T11:19:54-05:00April 10th, 2026|Payer Advocacy|

AASM addresses payer barriers to sleep care access

The American Academy of Sleep Medicine recently sent a letter to UnitedHealthcare, raising concerns about the use of Synapse Health for durable medical equipment (DME) fulfillment for CPAP therapy. The letter outlined member‑reported issues affecting patient access to care and clinical workflows. AASM [...]

2026-04-10T11:06:16-05:00April 10th, 2026|Payer Advocacy|

AASM develops downloadable payer template letter to address in-lab billing policies

The American Academy of Sleep Medicine recently sent a letter to Wellmark to raise concerns about a payer policy affecting reimbursement for in-lab diagnostic and titration sleep studies. The policy restricts reimbursement for Current Procedural Terminology (CPT) codes 95810 (diagnostic polysomnography) and 95811 (polysomnography with PAP titration) when [...]

2026-04-02T08:26:45-05:00April 1st, 2026|Payer Advocacy|
Go to Top